Oncology medicine franchise in Ahmedabad

Irinox 100 Injection contains Irinotecan 100 mg/5 ml, a potent anticancer medicine widely used in the treatment of colorectal cancer and various other malignancies as part of established chemotherapy regimens. It helps control the growth and spread of cancer cells by interfering with DNA replication and cellular division processes that are essential for tumor progression. The injection is administered under specialist supervision and serves as an important component of modern oncology treatment protocols.

Irinotecan belongs to the class of topoisomerase I inhibitors and works by preventing cancer cells from repairing and replicating their DNA. This disruption leads to the accumulation of genetic damage within rapidly dividing malignant cells, resulting in cell death and inhibition of tumor growth. Its targeted mechanism of action has established Irinotecan as a key therapeutic option in advanced cancer management, particularly in gastrointestinal oncology.

The injection is commonly prescribed for metastatic colorectal cancer and may also be utilized in the treatment of gastric cancer, pancreatic cancer, lung cancer, and other malignancies as determined by an oncology specialist. It is frequently administered in combination with other anticancer medicines to improve therapeutic outcomes and support comprehensive cancer care. Continuous medical monitoring throughout therapy is essential to ensure treatment effectiveness and patient safety.

With the increasing demand for advanced chemotherapy options and specialized oncology treatments, Irinox 100 Injection holds significant value in the anticancer segment. Its proven clinical efficacy, broad therapeutic applications, and inclusion in numerous chemotherapy protocols contribute to strong and consistent market demand. The product offers excellent business potential and sustainable growth opportunities for retailers and distributors operating within the oncology pharmaceutical sector.

Irinox 100 Injection may cause diarrhea, nausea, vomiting, abdominal pain, fatigue, weakness, loss of appetite, hair loss, and low blood cell counts. Bone marrow suppression, severe diarrhea, infections, anemia, bleeding tendencies, and allergic reactions may occur and require close medical supervision.

Irinox 100 Injection is indicated for the treatment of metastatic colorectal cancer, advanced colorectal cancer, gastric cancer, pancreatic cancer, lung cancer, and other malignancies as determined by an oncology specialist. It helps control cancer cell growth and supports comprehensive chemotherapy treatment regimens.

This medication should be administered only by qualified healthcare professionals experienced in cancer chemotherapy. Regular monitoring of blood counts, liver function, kidney function, hydration status, and overall patient condition is essential during treatment. Patients should immediately report severe diarrhea, fever, unusual bleeding, persistent vomiting, breathing difficulties, or signs of infection. Treatment should always be individualized according to the patient's condition and response to therapy.

Store in a cool, dry place below 25°C, protected from direct sunlight and moisture. Keep the vial in its original packaging until use and out of reach of children. Do not use after the expiry date or if the packaging is damaged, opened, or shows signs of deterioration.